Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions Q12. Is there any possibility that the payment of money by pharmaceutical companies to healthcare professionals may distort their activities or judgment?
Answer
In order to prevent such distortion, we have established a voluntary standard, the "Transparency Guideline," which discloses the expenses paid by pharmaceutical companies to healthcare professionals.
Although the payment of money by pharmaceutical companies to medical institutions should not distort the activities and judgment of medical professionals, it is undeniable that there may be concerns that such payments may have some influence on the judgment of medical professionals. It is precisely because of such concerns that we strive to ensure transparency, fairness, and neutrality by disclosing information on conflicts of interest between pharmaceutical companies and healthcare professionals through our transparency guidelines.